WINTON GROUP Ltd Buys 58,039 Shares of The Chemours Company $CC

WINTON GROUP Ltd raised its stake in The Chemours Company (NYSE:CC) by 103.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 114,100 shares of the specialty chemicals company’s stock after acquiring an additional 58,039 shares during the period. WINTON GROUP Ltd owned about 0.08% of Chemours worth $1,807,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of CC. State Street Corp boosted its stake in shares of Chemours by 22.7% in the 2nd quarter. State Street Corp now owns 6,114,328 shares of the specialty chemicals company’s stock valued at $70,009,000 after purchasing an additional 1,131,682 shares in the last quarter. Ameriprise Financial Inc. increased its position in shares of Chemours by 21.6% during the 2nd quarter. Ameriprise Financial Inc. now owns 4,216,064 shares of the specialty chemicals company’s stock worth $48,274,000 after purchasing an additional 748,052 shares in the last quarter. Geode Capital Management LLC lifted its holdings in Chemours by 41.4% during the 2nd quarter. Geode Capital Management LLC now owns 3,484,416 shares of the specialty chemicals company’s stock valued at $39,901,000 after purchasing an additional 1,020,933 shares during the last quarter. Scopia Capital Management LP boosted its position in Chemours by 71.7% in the second quarter. Scopia Capital Management LP now owns 3,355,261 shares of the specialty chemicals company’s stock valued at $38,418,000 after buying an additional 1,401,539 shares in the last quarter. Finally, American Century Companies Inc. grew its stake in Chemours by 26.0% during the third quarter. American Century Companies Inc. now owns 2,378,591 shares of the specialty chemicals company’s stock worth $37,677,000 after buying an additional 490,988 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on CC shares. The Goldman Sachs Group boosted their target price on Chemours from $14.00 to $18.00 and gave the stock a “neutral” rating in a report on Wednesday, February 25th. Morgan Stanley increased their target price on Chemours from $15.00 to $17.00 and gave the stock an “equal weight” rating in a report on Monday, February 23rd. Weiss Ratings restated a “sell (d)” rating on shares of Chemours in a research note on Wednesday, January 21st. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $18.00 price target on shares of Chemours in a report on Friday, January 16th. Finally, UBS Group increased their price objective on shares of Chemours from $18.00 to $23.00 and gave the stock a “buy” rating in a report on Monday, February 23rd. Five equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $18.40.

Chemours Trading Up 2.0%

Shares of CC opened at $17.76 on Wednesday. The stock’s fifty day simple moving average is $16.60 and its 200-day simple moving average is $14.78. The company has a quick ratio of 0.85, a current ratio of 1.78 and a debt-to-equity ratio of 16.33. The firm has a market capitalization of $2.67 billion, a PE ratio of -7.16 and a beta of 1.60. The Chemours Company has a 12-month low of $9.13 and a 12-month high of $21.85.

Chemours (NYSE:CC) last announced its quarterly earnings data on Thursday, February 19th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.33 billion. Chemours had a positive return on equity of 41.75% and a negative net margin of 6.41%.The company’s quarterly revenue was down 2.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.09 EPS. As a group, research analysts predict that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be paid a $0.0875 dividend. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.35 dividend on an annualized basis and a yield of 2.0%. Chemours’s dividend payout ratio (DPR) is presently -14.11%.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.